Peer Review History
Original SubmissionAugust 30, 2022 |
---|
PONE-D-22-24175A CNN-transformer fusion network for COVID-19 CXR image classificationPLOS ONE Dear Dr. Deng, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, the authors need to improve the description of methodology and compare the results with the state-of-the-art. Please submit your revised manuscript by Nov 10 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Robertas Damaševičius Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. New software must comply with the Open Source Definition. Additional Editor Comments: The authors need to improve the description of methodology and compare the results with the state-of-the-art. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The proposed machine learning solution is interesting and worth investigating. Moreover, comparison with state of art shows great efficiency. However, i cannot agree that the paper is ready for publication because of: 1) Discuss your proposition according to the newest approaches, especially in terms of other methods than a neural network. Why the proposed approach is worthy of investigation? For easier analysis, see such ideas as lung segmentation by a heuristic fox. 2) How did you model the architecture of CNN? 3) Some comparisons with learning transfer should be made. 4) Discussion on results is very limited. Reviewer #2: Abstract: The global health crisis due to the fast spread of coronavirus disease (Covid-19) has caused great danger to all aspects of healthcare, economy and other aspects. The highly infectious and insidious nature of the new coronavirus greatly increases the difficulty of outbreak prevention and control. The early and rapid detection of Covid-19 is an effective way to reduce the spread of Covid-19. However, detecting the Covid-19 accurately and quickly in large population remains to be a major challenge worldwide. In this study, A CNN-transformer fusion framework is proposed for the automatic classification of pneumonia on chest X-ray. This framework includes two parts: data processing and image classification. The data processing stage is to eliminate the differences between data from different medical institutions so that they have the same storage format; in the image classification stage, we use a multi-branch network with a custom convolution module and a transformer module, including feature extraction, feature focus and feature classification sub-networks. Feature extraction subnetworks extract the shallow features of the image and interact with the information through the convolution and transformer modules. Both the local and global features are extracted by the convolution module and transformer module of feature focus subnetworks, and are classified by the feature classification subnetworks. The proposed network could decide whether or not a patient has pneumonia, furthermore differentiate between Covid-19 and bacterial pneumonia. This network was implemented on the collected benchmark datasets and the result shows that accuracy, precision, recall and F1 score are 97.09%, 97.16%, 96.93% and 97.04%, respectively. Our network was compared with other researchers’ proposed methods and achieved better results in terms of accuracy, precision and F1 score, proving that it is superior for Covid-19 detection. With further improvements to this network, we hope that it will provide doctors with an effective tool for diagnosing Covid-19. Overall, the novelty is sufficient but still several issues remaining that should be incorporated. 1) "Covid-19 is a pulmonary disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 and is highly infectious, mutagenic, and Covid-19 and its novel mutant strains such as delta, omicron, and omicron XE variant have"- add the following two works for the support of this statement (A Healthcare System for COVID19 Classification Using Multi-Type Classical Features Selection; A Rapid Artificial Intelligence-based Computer-Aided Diagnosis System for COVID19 Classification from CT Images ) 2) Add the following studies in the related work, as the related work is not suffiecint and up to date. - COVID19 Classification using Chest X-Ray Images: A Framework of CNN-LSTM and Improved Max Value Moth Flame Optimization - COVID-19 Classification from Chest X-Ray Images: A Framework of Deep Explainable Artificial Intelligence 3) "According to the WHO, as of April 4, 2022, there were 489,779,062 confirmed cases of COVID-19 including 6,152,095 deaths "- this statement need to be confirmed with correct data 4) "There are a number of reasons for the lower sensitivity, such as the possible inadequate supply of reagents, the lack of expertise required for the testing, low viral load in patients and the long testing cycles."- this statement need some justifications 5) "Medical imaging and deep learning (DL) can play an important role in pre-detection efforts to combat disease. In recent years, researchers have used deep neural networks to achieve remarkable results in a variety of fields. Recent advances in DL show that computers can extract more information from images, more reliably, and more accurately than ever before"- add the following works for the support of this important statement: - Brain MRI analysis using deep neural network for medical of internet things applications - BrainNet: optimal deep learning feature fusion for brain tumor classification 6) The major contributions should be revised, as the last contribution (3) is not a contribution. 7) Draw figure 1 in more attractive. 8) It is important to add the images before and after the data augmentationn. 9) Remove Eq. 6-9, these are well known. 10) In table 7, what is reason behind the choice of these hyperparameters. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
A CNN-transformer fusion network for COVID-19 CXR image classification PONE-D-22-24175R1 Dear Dr. Deng, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Robertas Damaševičius Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All my comments have been addressed. In my opinion, the paper is ready for publication and can be accepted. Reviewer #2: Authors well revised this manuscript as per my recommendation. I have no more comments and this paper is ready for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
Formally Accepted |
PONE-D-22-24175R1 A CNN-transformer fusion network for COVID-19 CXR image classification Dear Dr. Deng: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Robertas Damaševičius Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .